Cardio-oncology’s modern approaches to prevent doxorubicin-induced cardiotoxicity: a systematic review

HIGHLIGHTS

  • What: The research question addressed interventions aimed at preventing DOX-induced search. The study by Myunhee Lee et_al aimed to ascertain if low-dose candesartan might effectively lower DOXinduced cardiotoxicity in female breast cancer patients who had not previously had cardiovascular risk factors following DOX treatment.
  • Who: Aadi R. Palvia et al. from the Medical College, Pune, IND Internal Medicine, Gitam Institute of Medical Sciences and Research, Visakhapatnam, Research Society (GMERS) Medical College, Vadodara, IND Internal Medicine, Mayo Clinic, Rochester, USA have published the research: Review began 07/28/2024 Review ended 07/31/2024 . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?